These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 26596588)
1. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. Seo JG; Park SP J Headache Pain; 2015; 16():97. PubMed ID: 26596588 [TBL] [Abstract][Full Text] [Related]
2. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. Seo JG; Park SP J Headache Pain; 2015; 16():65. PubMed ID: 26174509 [TBL] [Abstract][Full Text] [Related]
3. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447 [TBL] [Abstract][Full Text] [Related]
4. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study. Seo JG; Cho YW; Lee SJ; Lee JJ; Kim JE; Moon HJ; Park SP Epilepsy Behav; 2014 Jun; 35():59-63. PubMed ID: 24798411 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine. Seo JG; Park SP J Oral Facial Pain Headache; 2017 Summer; 31(3):251-256. PubMed ID: 28738110 [TBL] [Abstract][Full Text] [Related]
6. Rapid screening for generalized anxiety disorder in patients with migraine. Veisy F; Farahani H; Togha M; Gharaee B; Janani L; Aghebati A Curr J Neurol; 2021 Apr; 20(2):102-110. PubMed ID: 38011478 [No Abstract] [Full Text] [Related]
7. Validation of the Generalized Anxiety Disorder-7 (GAD-7) in Russian people with epilepsy. Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Voinova N; Popova S; Avedisova A; Guekht A Epilepsy Behav; 2021 Oct; 123():108269. PubMed ID: 34500434 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Tong X; An D; McGonigal A; Park SP; Zhou D Epilepsy Res; 2016 Feb; 120():31-6. PubMed ID: 26709880 [TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the 7-item Generalized Anxiety Disorder Scale (GAD-7) in a large representative sample of Finnish adolescents. Tiirikainen K; Haravuori H; Ranta K; Kaltiala-Heino R; Marttunen M Psychiatry Res; 2019 Feb; 272():30-35. PubMed ID: 30579178 [TBL] [Abstract][Full Text] [Related]
10. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6. Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772 [TBL] [Abstract][Full Text] [Related]
11. Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study. Fuller-Thomson E; Jayanthikumar J; Agbeyaka SK Headache; 2017 Mar; 57(3):375-390. PubMed ID: 27991658 [TBL] [Abstract][Full Text] [Related]
12. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662 [TBL] [Abstract][Full Text] [Related]
13. Adaptation of the two-item generalized anxiety disorder scale (GAD-2) to Chinese rural population: A validation study and meta-analysis. Luo Z; Li Y; Hou Y; Zhang H; Liu X; Qian X; Jiang J; Wang Y; Liu X; Dong X; Qiao D; Wang F; Wang C Gen Hosp Psychiatry; 2019; 60():50-56. PubMed ID: 31326672 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Validity of the Generalized Anxiety Disorder - 7 (GAD-7) among Pregnant Women. Zhong QY; Gelaye B; Zaslavsky AM; Fann JR; Rondon MB; Sánchez SE; Williams MA PLoS One; 2015; 10(4):e0125096. PubMed ID: 25915929 [TBL] [Abstract][Full Text] [Related]
15. Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample. Kertz S; Bigda-Peyton J; Bjorgvinsson T Clin Psychol Psychother; 2013; 20(5):456-64. PubMed ID: 22593009 [TBL] [Abstract][Full Text] [Related]
16. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study. Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620 [TBL] [Abstract][Full Text] [Related]
17. Norwegian version of the rating anxiety in dementia scale (RAID-N): a validity and reliability study. Goyal AR; Bergh S; Engedal K; Kirkevold M; Kirkevold Ø Aging Ment Health; 2017 Dec; 21(12):1256-1261. PubMed ID: 27584559 [TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of the traditional Chinese version of the GAD-7 in Taiwanese patients with epilepsy. Shih YC; Chou CC; Lu YJ; Yu HY J Formos Med Assoc; 2022 Nov; 121(11):2324-2330. PubMed ID: 35584970 [TBL] [Abstract][Full Text] [Related]
19. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. Beard C; Björgvinsson T J Anxiety Disord; 2014 Aug; 28(6):547-52. PubMed ID: 24983795 [TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of the Portuguese version of the Generalized Anxiety Disorder (GAD-7) scale. Sousa TV; Viveiros V; Chai MV; Vicente FL; Jesus G; Carnot MJ; Gordo AC; Ferreira PL Health Qual Life Outcomes; 2015 Apr; 13():50. PubMed ID: 25908249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]